okebet opisyal na website Orlando City 1, Atlanta 0The said Friday that will remain in Miami for the final two games of their road trip before rejoining the team next week. Miami visits the on Saturday and then the on Sunday. They'll be back at home Wednesday to play the . The team is citing a return to competition reconditioning for Butler's absence, the same reason he missed its win over the on Thursday. Friday's update came a day after Heat president Pat Riley said the team is not trading Butler this season. League sources previously told ESPN's Shams Charania that the six-time All-Star Butler prefers a trade out of Miami ahead of the Feb. 6 deadline, and that he's open to trade destinations such as the , , and Houston Rockets. "We usually don't comment on rumors, but all this speculation has become a distraction to the team and is not fair to the players and coaches. Therefore, we will make it clear -- we are not trading Jimmy Butler," Riley said in a statement. Butler twisted an ankle in Miami's loss to the last Friday. He missed the remainder of that game and the next two Heat games -- at the Magic on Saturday and against the on Monday -- but with illness, not the ankle, cited as the reason. Butler, 35, is averaging 18.5 points, 5.8 rebounds and 4.9 assists this season. He is one of the NBA's elite competitors and a perennial postseason performer. His teams have made the playoffs in 12 of his first 13 seasons, including the five previous seasons in Miami, where he has led the Heat to two NBA Finals berths and one additional Eastern Conference finals appearance. (heel) also won't face the Hawks, the team said Friday.

NEW YORK, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated ELAN and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated . Investors have until December 6, 2024 to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Elanco Animal Health Incorporated securities. The case is pending in the U.S. District Court of Maryland and is captioned Barpar v. Elanco Animal Health Incorporated , et al. , No. 24-cv-02912. What is the Lawsuit About? The complaint alleges that Elanco develops products to treat diseases in animals. Two of the most important treatments in the company's development pipeline are currently being reviewed by the U.S. Food and Drug Administration ("FDA"). The treatments are named Zenrelia, a drug for a type of dermatitis in dogs, and Credelio Quattro, which is a broad spectrum oral parasiticide covering fleas, ticks and internal parasites. With respect to these treatments, the company stated that the FDA "has all data necessary to complete its review. All technical sections, including the label, are expected to be approved before the end of June [2024]." However, on June 27, 2024, Elanco announced that it expected the FDA would not approve either drug in June 2024 and that Zenrelia would come with a boxed warning on safety. As a result of the news, Elanco's stock price declined over 21%, from $17.97 per share on June 26, 2024 to $14.27 per share on June 27, 2024. BFA Law is investigating whether Elanco and certain of its executives made materially false and/or misleading statements to investors related to the FDA's approval of its drugs. Click here if you suffered losses: https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated . What Can You Do? If you invested in Elanco Animal Health Incorporated ELAN you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated Or contact: Ross Shikowitz ross@bfalaw.com 212-789-3619 Why Bleichmar Fonti & Auld LLP? Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit https://www.bfalaw.com . https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated Attorney advertising. Past results do not guarantee future outcomes. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.UFC 310 mailbag: What’s next for Alexandre Pantoja and did Shavkat Rakhmonov’s stock drop?

Three Studs, One Dud From Celtics’ Energizing Win Over Timberwolves - NESN

The Eagles are looking to clinch the NFC East title while completing a rare sweep of the rival Dallas Cowboys on Sunday in Philadelphia. The Eagles (12-3) will have to play without starting quarterback Jalen Hurts, who sustained a concussion during last weekend's 36-33 loss at Washington that snapped their team-record 10-game winning streak. He was ruled out on Friday after missing practice all week. Backup quarterback Kenny Pickett suffered a rib injury against the Commanders, but he was a full participant at Thursday's practice and was limited on Friday. Pickett is expected to start, with Tanner McKee his backup on Sunday as Philadelphia tries to sweep Dallas for the first time since 2011. Meanwhile, the Cowboys (7-8) are clicking with their own QB2 at the controls. Cooper Rush has guided Dallas to wins in four of the last five games, throwing nine touchdown passes and just one interception in that span. The Cowboys are in the unfamiliar position of playing spoiler, missing the playoffs for the first time since 2020. Two more wins would give Dallas its fourth straight winning season under fifth-year coach Mike McCarthy. "It's hard to win games in this league. It's definitely an end goal just to have a winning season," Cowboys right guard Brock Hoffman said. "... But definitely where we've been at on this journey, take it week by week, win these last two games, have a winning season, and it's definitely a big boost going into next season." The Eagles cruised to a 34-6 win over the Cowboys in Arlington, Texas, in the first meeting in Week 10, with Hurts throwing two touchdown passes and rushing for two scores. Rush finished with just 45 yards on 13-of-23 passing. Pickett replaced a woozy Hurts in the first quarter against Washington and finished the drive with a touchdown pass to A.J. Brown. "I thought it was so cool for our guys to have the confidence in (Pickett) to just hop in there and handle a third down, handle another completion, throw a third-down touchdown in the red zone," Eagles offensive coordinator Kellen Moore said Tuesday. "I thought that was a really cool moment." A sixth-round pick out of Stanford in 2023, McKee has yet to appear in a regular-season game. "I feel like I've always been preparing to be the starter and preparing to play, and so my preparation is going to stay the same," McKee said Tuesday. "And you know, I'm obviously excited for any opportunity that I do get, but we're going to take it day by day for those guys." No matter who plays QB, the Eagles likely will lean heavily on Saquon Barkley. With a league-leading 1,838 rushing yards, he needs 268 in the last two games to break Eric Dickerson's 1984 NFL single-season record of 2,105. Philadelphia's injury report Friday also included the team ruling out wide receiver Britain Covey (neck), who also returns punts, and running back Will Shipley (concussion), a contributor on kickoff return duty. Linebacker Nakobe Dean (abdomen) is doubtful after limited participation on Friday, while defensive end Bryce Huff (wrist) was a full participant and listed as questionable. He would need to be activated from injured reserve to play on Sunday. The Cowboys have shut down star wideout CeeDee Lamb for the rest of the season because of a sprained right shoulder. Also ruled out for Sunday are cornerbacks Kemon Hall (hamstring) and Amani Oruwariye (foot). Guard TJ Bass (thigh) is doubtful, while those with questionable status are wide receivers Jalen Brooks (knee) and Jalen Tolbert (finger), offensive tackles Chuma Edoga (toe) and Asim Richards (ankle), linebackers Eric Kendricks (calf) and Nick Vigil (foot), and safety Donovan Wilson (knee). --Field Level Media

El Salvador lawmakers overturn mining ban in win for president

Texas sues NCAA to block transgender athletesCellectis announces the drawdown of the third tranche of €5 million under the credit facility ...

Under-fire manager SWEARS live on Amazon Prime as Gabby Logan laughs awkwardly weeks after she was forced to apologiseThanksgiving roast turkey with sage and onion stuffing recipe

NoneKeanu Reeves says he joined Sonic The Hedgehog 3 cast as he is ‘a big fan’